Company news
Shanghai Kaikai Industrial Co., Ltd. news in 2026
Shanghai Kaikai Industrial Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Use of Idle Self-owned Funds to Purchase Bank Wealth Management Products
November 6, 2026
(600272)"Shanghai Kai Kai Industrial Company Limited"Report for Q3 2026
October 29, 2026
(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Resolutions of the 6th Meeting of the 11th Board of Directors
October 29, 2026
(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Key Operating Data for the First Three Quarters of 2026
October 29, 2026
(600272)"Shanghai Kai Kai Industrial Company Limited"Announcement on Use of Idle Self-owned Funds to Purchase Bank Wealth Management Products
October 23, 2026
Announcement on Use of Idle Self-owned Funds to Purchase Bank Wealth Management Products
September 28, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 18, 2026
Announcement on Participation in and Summary of the 2026 Collective Reception Day for Listed Companies in Shanghai Jurisdiction and Interim Performance Briefing
September 16, 2026
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
September 10, 2026
Announcement on Change of Non-independent Director
August 28, 2026
Announcement on Abnormal Fluctuations in Stock Trading and Risk Warning
August 18, 2026
Announcement on Risk Warning in Stock Trading
August 11, 2026
Announcement on Abnormal Fluctuations in Stock Trading
August 10, 2026
Announcement on Progress of Authorizing the Wholly-owned Subsidiary, Shanghai Leiyunshang Pharmaceutical West Co., Ltd., to Acquire the Minority Equity Interest in Its Controlled Subsidiary, Shanghai Leixi Jingyi Supply Chain Management Co., Ltd.
August 6, 2026
Announcement on Using Idle Self-owned Funds to Purchase Bank Financial Products
July 31, 2026
Announcement on the Authorization of the Wholly-Owned Subsidiary, SHANGHAI LEIYUNSHANG PHARMACEUTICAL CO,. LTD., to Acquire the Minority Equity Interest in Its Controlled Subsidiary, Shanghai Leixi Jingyi Supply Chain Management Co., Ltd.
July 17, 2026
Announcement on Expected Increase in Semi-annual Performance for 2026
July 14, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 29, 2026
Announcement on Completion of Capital Increase to Wholly-owned Subsidiary Shanghai Leiyunshang Pharmaceutical West District Co., Ltd.
June 12, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 5, 2026
Indicative Announcement on Convening the 2025 Annual General Meeting
May 29, 2026
Announcement on Progress in Capital Increase to Wholly-owned Subsidiary Shanghai Leiyunshang Pharmaceutical West District Co., Ltd.
May 15, 2026
Announcement on Attending Annual Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2026
May 7, 2026
Notice on Convening the 2025 Annual General Meeting
April 29, 2026
Announcement on Actual Amount Incurred in Daily Related Party Transactions in 2025 and Daily Related Party Transactions in 2026
March 27, 2026
Announcement on Using Idle Self-owned Funds to Purchase Bank Financial Products
March 24, 2026
Announcement on Completion of Transfer of 11.11% Equity in Nanjing Tianshi Software Technology Co., Ltd.
February 12, 2026
Announcement on Cancellation of Special Accounts for Raised Funds
January 29, 2026
Announcement on Expected Decrease in Performance for 2025
January 23, 2026
Announcement on Progress in Transfer of 11.11% Equity in Nanjing Tianshi Software Technology Co., Ltd.
January 13, 2026